2024年8月6日，美股上市公司I-Mab
(NASDAQ:IMAB)
董事会审计委员会批准
解除普华永道中天会计师事务所(“普华永道中国”)
作为公司独立注册会计师事务所的职务，自2024年8月7日起生效，并
任命普华永道会计师事务所(“普华永道美国”)
为公司截至2024年12月31日的新独立注册会计师事务所。
I-Mab是一家总部位于美国的全球性生物技术公司，专注于开发和潜在商业化用于治疗癌症的高度分化免疫疗法。
I-Mab董事会成员兼临时首席执行官Sean Fu表示:“I-Mab继续朝着我们成为美国生物技术公司的战略目标取得卓越进展。“
任命普华永道美国公司为我们的美国审计公司是这一转型的另一个重要里程碑，强调了我们的进步和对董事会确定的战略和愿景的承诺。”
I-Mab预计，向美国审计公司的过渡将使公司能够继续遵守《外国控股公司责任法案》的审计要求，并促进公司向一家成熟的美国生物技术公司的持续过渡。这一过渡不是由于与公司前任审计师有任何分歧、可报告事件、修改意见或未解决的问题，也不需要向公司股东提请注意有关过渡的任何事项。
I-Mab首席财务官约瑟夫•斯凯尔顿表示:“非常荣幸与普华永道美国公司合作，并相信他们作为我们美国审计机构的参与符合我们股东的长期利益。”我们将继续发展和推进我们的组织和公司治理，重点是支持I-Mab的长期增长，并期待让投资者了解我们的最新进展。”
原英文报道如下：
ROCKVILLE, Md., Aug. 7, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) ("I-Mab", the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that the Audit Committee of its Board of Directors has approved the appointment of PricewaterhouseCoopers LLP (U.S.) ("PwC US") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, effective immediately.
"I-Mab continues to achieve excellent progress towards our strategic objective of becoming a U.S.-based biotech," said Sean Fu, PhD, Board Member and Interim Chief Executive Officer of I-Mab. "The appointment of PwC US as our U.S. auditor is another important milestone in this transition, underscoring our progress and commitment to the strategy and vision defined by the Board."
I-Mab expects that the transition to a U.S. audit firm will enable the Company to continue to comply with the audit requirements of the Holding Foreign Companies Accountable Act and facilitate the continued transition of the Company to a full-fledged U.S.-based biotech company. This transition was not the result of any disagreements, reportable events, modified opinions, or unresolved matters with the Company's previous auditor, and no matters regarding the transition need to be brought to the attention of the Company's shareholders.
"We are enthusiastic to work with PwC US and believe that their engagement as our U.S. auditor aligns with the long-term interests of our shareholders," said Joseph Skelton, Chief Financial Officer of I-Mab. "We continue to grow and advance our organization and corporate governance with a focus on supporting I-Mab's long-term growth and look forward to keeping investors up to date on our progress."
四大君重磅推出职场
圈子小程序！
入圈可实时了解四大圈职场的最新资讯、专业知识经验、政策解读等；在线收听圈内资深人士的职场和专业话题分享；通过与圈内职场经验人士互动解决自身的各种职场疑惑；下载本圈收集的各种数据报告、专业干货等，进行自我学习提升。
点击下方“财融圈”小程序，即可加入我们！
